Trial – AMGEN/IQVIA
Suffering from Chronic Hives?
A 32-week Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging, Phase 2b Study to Evaluate Efficacy and Safety of xxxxxxxxxx for the Treatment of Chronic Spontaneous Urticaria
Males and Females between the ages of 18-80 may qualify.
To participate in your local study, please contact (949) 844-0442 or fill out the form below.
Protocol # 20190194
Lorem ipsum dolor sit amet, consectetur adiop iscing elit, sed do eiusmod tempor inci didunt ult labore et dolore magna aliqua.